Spruce Biosciences's market cap is currently $4.36M. The company's EPS TTM is $-3.5; its P/E ratio is ―; Spruce Biosciences is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $-15.56. See an overview of income statement, balance sheet, and cash flow financials.
